--- title: Innovation Index Cure Preview --- ## See What Moves Science Forward. The Cure Innovation Index is the first evidence-based platform helping you pinpoint where performance is falling short and what to invest in next to improve translational outcomes. [Request a Demo](https://wewillcure.com/c/innovation-index-cure-preview#bottom-form-scroll) [See What Makes Institutions Innovative](https://wewillcure.com/c/innovation-index-cure-preview#whitepaper-scroll) ![](https://wewillcure.com/hubfs/Group%2040.png) ## As featured in - [![reuters](https://wewillcure.com/hubfs/reuters.png)](https://www.reuters.com/business/healthcare-pharmaceuticals/china-closing-us-still-leads-biotech-innovation-survey-finds-2026-06-22/) - [![stat](https://wewillcure.com/hubfs/stat.png)](https://www.statnews.com/pharmalot/2026/06/24/fda-commissioner-candidate-germany-plans-for-drug-prices/) - [![usnews](https://wewillcure.com/hubfs/usnews.png)](https://money.usnews.com/investing/news/articles/2026-06-22/china-closing-in-but-us-still-leads-in-biotech-innovation-survey-finds) - [![cna](https://wewillcure.com/hubfs/cna.png)](https://youtu.be/-OSP8HY-IrU?t=1576) - [![pharmaphorum](https://wewillcure.com/hubfs/pharmaphorum.png)](https://pharmaphorum.com/news/hhs-details-plan-regain-uss-edge-clinical-trials) - [![cnen](https://wewillcure.com/hubfs/cnen.png)](https://cen.acs.org/policy/research-funding/New-York-center-ranks-academic/104/web/2026/04) - [![aa](https://wewillcure.com/hubfs/aa.png)](https://www.aa.com.tr/en/science-technology/biotech-rivalry-between-us-china-intensifies-poll/3974988) - [![epoch](https://wewillcure.com/hubfs/epoch.png)](https://www.theepochtimes.com/us/survey-finds-china-threatening-us-lead-in-biotech-innovation-6051832) - [![he](https://wewillcure.com/hubfs/he.png)](https://healthexec.com/topics/healthcare-management/healthcare-policy/us-have-stay-ahead-china-medical-advancement) - [![pharmam](https://wewillcure.com/hubfs/pharmam.png)](https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/55385857/us-biotech-leadership-at-risk-as-china-dominates-manufacturing-survey) - [![01 Reuters LogoM](https://wewillcure.com/hubfs/01%20Reuters%20LogoM.png)](https://www.reuters.com/business/healthcare-pharmaceuticals/china-closing-us-still-leads-biotech-innovation-survey-finds-2026-06-22/) - [![03 stat logo 1](https://wewillcure.com/hubfs/03%20stat%20logo%201.png)](https://www.statnews.com/pharmalot/2026/06/24/fda-commissioner-candidate-germany-plans-for-drug-prices/) - [![02 U.S.\_News\_&\_World\_Report\_logo 1](https://wewillcure.com/hubfs/02%20U.S._News_%26_World_Report_logo%201.png)](https://money.usnews.com/investing/news/articles/2026-06-22/china-closing-in-but-us-still-leads-in-biotech-innovation-survey-finds) - [![04 CNA\_new\_logo 1](https://wewillcure.com/hubfs/04%20CNA_new_logo%201.png)](https://youtu.be/-OSP8HY-IrU?t=1576) - [![pharmapM](https://wewillcure.com/hubfs/pharmapM.png)](https://pharmaphorum.com/news/hhs-details-plan-regain-uss-edge-clinical-trials) - [![05 cen-logo 1](https://wewillcure.com/hubfs/05%20cen-logo%201.png)](https://cen.acs.org/policy/research-funding/New-York-center-ranks-academic/104/web/2026/04) - [![06 Anadolu\_Agency\_logo 1](https://wewillcure.com/hubfs/06%20Anadolu_Agency_logo%201.png)](https://www.aa.com.tr/en/science-technology/biotech-rivalry-between-us-china-intensifies-poll/3974988) - [![07 epoch-times-logo 1](https://wewillcure.com/hubfs/07%20epoch-times-logo%201.png)](https://www.theepochtimes.com/us/survey-finds-china-threatening-us-lead-in-biotech-innovation-6051832) - [![09 healthexec-logo 1](https://wewillcure.com/hubfs/09%20healthexec-logo%201.png)](https://healthexec.com/topics/healthcare-management/healthcare-policy/us-have-stay-ahead-china-medical-advancement) - [![pharmamM](https://wewillcure.com/hubfs/pharmamM.png)](https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/55385857/us-biotech-leadership-at-risk-as-china-dominates-manufacturing-survey) - [![](https://wewillcure.com/hubfs/01%20Reuters%20LogoM.png)](https://www.reuters.com/business/healthcare-pharmaceuticals/china-closing-us-still-leads-biotech-innovation-survey-finds-2026-06-22/) - [![](https://wewillcure.com/hubfs/03%20stat%20logo%201.png)](https://www.statnews.com/pharmalot/2026/06/24/fda-commissioner-candidate-germany-plans-for-drug-prices/) - [![](https://wewillcure.com/hubfs/02%20U.S._News_%26_World_Report_logo%201.png)](https://money.usnews.com/investing/news/articles/2026-06-22/china-closing-in-but-us-still-leads-in-biotech-innovation-survey-finds) - [![](https://wewillcure.com/hubfs/04%20CNA_new_logo%201.png)](https://youtu.be/-OSP8HY-IrU?t=1576) - [![](https://wewillcure.com/hubfs/pharmapM.png)](https://pharmaphorum.com/news/hhs-details-plan-regain-uss-edge-clinical-trials) - [![](https://wewillcure.com/hubfs/05%20cen-logo%201.png)](https://cen.acs.org/policy/research-funding/New-York-center-ranks-academic/104/web/2026/04) - [![](https://wewillcure.com/hubfs/06%20Anadolu_Agency_logo%201.png)](https://www.aa.com.tr/en/science-technology/biotech-rivalry-between-us-china-intensifies-poll/3974988) - [![](https://wewillcure.com/hubfs/07%20epoch-times-logo%201.png)](https://www.theepochtimes.com/us/survey-finds-china-threatening-us-lead-in-biotech-innovation-6051832) - [![](https://wewillcure.com/hubfs/09%20healthexec-logo%201.png)](https://healthexec.com/topics/healthcare-management/healthcare-policy/us-have-stay-ahead-china-medical-advancement) - [![](https://wewillcure.com/hubfs/pharmamM.png)](https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/55385857/us-biotech-leadership-at-risk-as-china-dominates-manufacturing-survey) ## What This Means for Your Institution 1 ### Clear performance visibility Get a full view of how your institution performs on the metrics that matter for translational impact. 2 ### Relevant peer benchmarking Compare against institutions with similar research scale, clinical capability, ecosystem maturity, funding, and geography. Not arbitrary lists. 3 ### A narrative you can use Turn complex data into a clear, defensible, board-ready story in plain language. No internal scramble before every trustee meeting. 4 ### A path to improvement Identify what to change and where to invest next with targeted guidance and resources. A prioritized investment plan, not just a diagnosis. [Request a Demo](https://wewillcure.com/c/innovation-index-cure-preview#bottom-form-scroll) ## Most Platforms Give You Data. Not Direction. You track publications, patents, and funding. But these metrics don’t tell you what’s working, what isn’t, or where to invest next. The Cure Innovation Index benchmarks 303 U.S. research institutions, comparing your performance against similar institutions to pinpoint gaps, surface recommendations, and show where to act next across three domains. Research Capabilities The scientific strength, infrastructure, and funding base that enables high-impact biomedical discoveries. Entrepreneurial Readiness How effectively institutions prepare and support researchers to pursue biomedical innovation and commercialization. Market Translation How successfully institutions convert scientific discoveries into real-world health innovations. ## “It’s difficult for academic institutions to translate discovery into real-world impact. The Cure Innovation Index brings clarity to where that translation is working and where it isn’t.” Thomas P. Sakmar, MD
 Professor, Chemical Biology, Rockefeller University ## Answer the Questions That Drive Decisions Understand where you stand, where the gaps are, and where to focus next.  Where do we stand? See your position across translational performance. ![Where do we stand?](https://wewillcure.com/hubfs/Frame%20133%20(5)-1.png) Where are we strong? Identify areas of competitive advantage. ![Where are we strong?](https://wewillcure.com/hubfs/Frame%20133%20(6)-1.png) Where are we falling behind? Spot gaps using peer benchmarks. ![Where are we falling behind?](https://wewillcure.com/hubfs/Frame%20133%20(7).png) What should we invest in next? Get targeted recommendations. ![What should we invest in next?](https://wewillcure.com/hubfs/Frame%20133%20(8).png) How do we explain this internally? Turn data into a clear, usable narrative. ![How do we explain this internally?](https://wewillcure.com/hubfs/Frame%20133%20(9).png) ![Where do we stand?](https://wewillcure.com/hubfs/Frame%20133.png) ![Where are we strong?](https://wewillcure.com/hubfs/Frame%20133%20(1).png) ![Where are we falling behind?](https://wewillcure.com/hubfs/Frame%20133%20(2).png) ![What should we invest in next?](https://wewillcure.com/hubfs/Frame%20133%20(3).png) ![How do we explain this internally?](https://wewillcure.com/hubfs/Frame%20133%20(4).png) [Request a Demo](https://wewillcure.com/c/innovation-index-cure-preview#bottom-form-scroll) ## “The risk isn’t a lack of breakthroughs, it’s that we’re not investing enough in translating them into real-world impact. The Cure Innovation Index shows what it actually takes for institutions to bring discoveries to market.” Seema Kumar
 Chief Executive Officer,Cure ## Built on Rigorous Methodology 303 institutions ranked from 6,000+ considered 3 dimensions, 10 subdomains, 25 indicators Data from NIH, NSF, ClinicalTrials.gov, and more Peer benchmarking 
based on deciles Institution-level data 
remains private  Guided by industry leaders, including individuals from our affiliate, Deerfield Management ## What Makes Institutions Innovative See what separates leading institutions from the rest. Based on analysis of the top research institutions in the U.S., this whitepaper outlines what drives translational performance and where to focus to improve. Download the Report ## The Index Shows Where You Stand. Membership Helps You Act On It. [Schedule a Call to Learn More](https://wewillcure.com/c/innovation-index-cure-preview#bottom-form-scroll) ## INSTITUTION MEMBERSHIP Built for institutions looking to act on their Innovation Index results and strengthen translational performance. Access for campus entrepreneurs Data and insights from the Cure Innovation Index Concept to Cure masterclasses 2 Expert office hours on a topic of your choice Training on translating science to market from accredited courses Dedicated space within the Cure community for your institution Access to Cure events in NYC focused on translational research [Schedule a Call to Learn More](https://wewillcure.com/c/innovation-index-cure-preview#bottom-form-scroll) ## Understand How The Index Works for Your Institution Request a call to explore the platform and membership. See how it can help you identify gaps, prioritize investment, and strengthen translational performance. #### About [Our Mission](https://wewillcure.com/about?hsLang=en) [Our Team](https://wewillcure.com/community/leadership?hsLang=en) [Newsroom](https://wewillcure.com/newsroom?hsLang=en) [Partnerships and Sponsorships](https://wewillcure.com/partnerships?hsLang=en) #### Get in touch [Contact us](https://wewillcure.com/contact-us?hsLang=en) [Apply for Membership](https://wewillcure.com/membership?hsLang=en) [Newsletter Sign Up](https://wewillcure.com/newsletter?hsLang=en) #### Privacy [Privacy Policy](https://wewillcure.com/privacy-policy?hsLang=en) [Terms of Use](https://wewillcure.com/terms-and-conditions?hsLang=en) © 2025 Cure Experience Services, LLC. All Rights Reserved. × ### What Makes Institutions Innovative